Victor Miriame 4
4 · REVVITY, INC. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Revvity (RVTY) SVP Victor Miriame Exercises Options, Sells Shares
What Happened
Victor Miriame, Senior Vice President and Chief Commercial Officer of Revvity (RVTY), exercised options to acquire 1,862 shares and sold those 1,862 shares in an open-market transaction on February 24, 2026. The reported exercise price was $95.74 (exercise cost $178,268) and the shares were sold at $97.13 for total gross proceeds of $180,856. The sale was effected the same day as the exercise (a cashless exercise / immediate sale).
Key Details
- Transaction date: 2026-02-24.
- Exercise: 1,862 shares at $95.74 (reported acquisition cost $178,268).
- Sale: 1,862 shares at $97.13, total proceeds $180,856.
- Filing notes a related "derivative" acquisition of 1,862 shares at $0.00 (reported on the Form 4).
- Sale executed under a 10b5-1 trading plan adopted November 26, 2025 (footnote F1).
- Option vesting note: option became exercisable in three equal annual installments beginning March 1, 2020 (footnote F2).
- Shares owned after the transaction: not specified in the information provided.
- Filing date: 2026-02-26 (reported promptly after the Feb 24 transaction; no late filing flagged).
Context
Because the shares were exercised and sold the same day, this is a routine cashless exercise followed by an open-market sale rather than a buy signal. The sale was implemented under a pre-established 10b5-1 plan, which typically schedules sales in advance and is intended to avoid questions about timing. The net pre-tax difference between proceeds and exercise cost on this transaction is modest (roughly $2,588), though final tax/net cash outcomes depend on withholding and other factors not detailed in the filing.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-24$95.74/sh+1,862$178,268→ 19,984 total - Sale
Common Stock
[F1]2026-02-24$97.13/sh−1,862$180,856→ 18,122 total - Exercise/Conversion
NQ Stock Option (right to buy)
[F2]2026-02-24+1,862→ 0 totalExercise: $95.74Exp: 2026-03-01→ Common Stock (1,862 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2025.
- [F2]This option became exercisable in three equal annual installments beginning on March 1, 2020, which was the first anniversary of the date on which the option was granted.